Literature DB >> 23429019

Surveillance without chemotherapy in a woman with recurrent molar pregnancy.

Rashmi Bagga1, Sujata Siwatch, Radhika Srinivasan, Lakhbir Kaur Dhaliwal.   

Abstract

A 27-year-old fouth gravida patient with previous two partial molar pregnancies and one missed abortion underwent a suction evacuation for partial molar pregnancy at 9 weeks of gestation. She was followed up with serum HCG values. Though the HCG level reduced from a pre-evacuation value of 1 40 223-31 157 mIU/ml 1 week post procedure, the levels continued to be positive in low titres 6 months after suction evacuation. The management options were discussed with the patient and a decision was taken to continue surveillance with serial HCG titres. HCG levels normalised after 11 months without the need for chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429019      PMCID: PMC3603678          DOI: 10.1136/bcr-2012-008128

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Placental site trophoblastic tumour arising from a partial hydatidiform mole.

Authors:  Carlo Palmieri; Rosemary A Fisher; Neil J Sebire; Iain Lindsay; J Richard Smith; W Glenn McCluggage; Phillip Savage; Michael J Seckl
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

2.  Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.

Authors:  Barry W Hancock; Kauzer Nazir; Janet E Everard
Journal:  J Reprod Med       Date:  2006-10       Impact factor: 0.142

3.  Recurrent partial hydatidiform mole: a report of a patient with three consecutive molar pregnancies.

Authors:  S Koc; O Ozdegirmenci; G Tulunay; N Ozgul; M F Kose; D Bulbul
Journal:  Int J Gynecol Cancer       Date:  2006 Mar-Apr       Impact factor: 3.437

4.  Choriocarcinoma and partial hydatidiform moles.

Authors:  M J Seckl; R A Fisher; G Salerno; H Rees; F J Paradinas; M Foskett; E S Newlands
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

5.  Management and outcome of healthy women with a persistently elevated beta-hCG.

Authors:  Carlo Palmieri; Tony Dhillon; Rosemary Ann Fisher; Anna-Mary Young; Delia Short; Hugh Mitchell; Carol Aghajanian; Philip Michael Savage; Edward Stewart Newlands; Barry W Hancock; Michael J Seckl
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

6.  Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases.

Authors:  Laurence A Cole; Carolyn Y Muller
Journal:  Gynecol Oncol       Date:  2009-10-12       Impact factor: 5.482

7.  Hydatidiform mole in England and Wales 1973-83.

Authors:  K D Bagshawe; J Dent; J Webb
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

8.  Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study.

Authors:  Peter Schmid; Yutaka Nagai; Roshan Agarwal; Barry Hancock; Philip M Savage; Neil J Sebire; Iain Lindsay; Michael Wells; Rosemary A Fisher; Delia Short; Edward S Newlands; Manfred B Wischnewsky; Michael J Seckl
Journal:  Lancet       Date:  2009-06-22       Impact factor: 79.321

9.  Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study.

Authors:  Roshan Agarwal; Suliana Teoh; Delia Short; Richard Harvey; Philip M Savage; Michael J Seckl
Journal:  Lancet       Date:  2011-11-28       Impact factor: 79.321

10.  The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours.

Authors:  T Powles; A Young; A Sanitt; A Sammit; J Stebbing; D Short; M Bower; P M Savage; M J Seckl; P Schmid
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.